Influence of Continuous Luteinizing Hormone-Releasing Hormone Agonist Treatment on Steroidogenic Enzymes in the Human Testis

REFERENCES

• Allenmark S, Berg A Å:son, Hammar M, Lindström E. Combined paper and reversed-phase high-performance liquid chromatography method for the study of pregnenolone and progesterone metabolites. J Chromatogr 1981; 224: 399–405.
   Web of Science ®Google Scholar
• Bambino TA, Schreiber JK, Hsueh AJW. GnRH and its agonist inhibit testicular LH receptors and steroidogenesis in immature and adult hypophysectomised rats. Endocrinol 1980; 107: 908–917.
   PubMed Web of Science ®Google Scholar
• Berg Å:son A, Hammar M, Kjessler B. Analysis of steroid conversion in vitro by testicular tissue as a means of selection of infertile males for gonadotrophic substitution therapy. Int J Andrology 1983; 6: 12–24.
   PubMedGoogle Scholar
• Bhasin S, Heber D, Steiner BS, Handelsman DJ, Swerdloff RS. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen. J Clin Endocrinol Metab 1985; 60: 998–1003.
   PubMed Web of Science ®Google Scholar
• Bouchard P, Lagoguey M, Brailly S, Schaison G. GnRH pulsatile administration restores LH pulsatility and normal testosterone levels in males with hyperprolactinemia. J Clin Endocrinol Metab 1985; 60: 258–260.
   PubMed Web of Science ®Google Scholar
• Bramley TA, Menzies GS. Subcellular fractionation of the human corpus luteum: distribution of GnRH agonist binding sites. Mol Cell Endocrinol 1986; 45: 27–36.
   PubMed Web of Science ®Google Scholar
• Clayton RN, Katikineni M, Chan V, Defau ML, Catt KJ. Direct inhibition of testicular function by gonadotropin-releasing hormone: Mediation by specific gonadotropin-releasing hormone receptors in interstitial cells. Proc Natl Acad Sci USA 1980; 77: 4459–4463.
   PubMed Web of Science ®Google Scholar
• Clayton RN, Huhtaniemi IT. Absence of gonadotrophin-releasing hormone receptors in human gonadal tissue. Nature 1982; 299: 56–59.
   PubMed Web of Science ®Google Scholar
• Evans RM, Doelle GC, Lindner J, Bradley V, Rabin D. A luteinizing hormone-releasing hormone agonist decreases biological activity and modifies chromatographic behavior of luteinizing hormone in man. J Clin Invest 1984; 73: 262–266.
   PubMed Web of Science ®Google Scholar
• Hammar M, Berg A Å:son, Kjessler B. In vitro metabolism of 3H-Pregnenolone and H-Progesterone by adult and prepubertal human testicular tissue before and during gonadotrophic treatment. Archives of Andrology 1985; 14: 21–28.
   PubMed Web of Science ®Google Scholar
• Huhtaniemi I, Nikula H, Rannikko S. Treatment of prostatic cancer with a Gonadotropin-releasing hormone agonist analog: Acute and long term effects on endocrine functions of testicular tissue. J Clin Endocrinol Metab 1985; 61: 698–704.
   PubMed Web of Science ®Google Scholar
• Jaramillo Jaramillo C, Pérez-Infante V, Lopez Macia A, Charro Salgodo A, Coy DH, Schally AV. Serum LH, FSH and testosterone response to the administration of a new LH-RH analog, D-Trp6-LH-RH, in normal men. Int J Fertil 1977; 22: 77–84.
   PubMedGoogle Scholar
• Meldrum DR, Tsao Z, Monroe SE, Braunstein GD, Sladek J, Lu JKH, Vale W, Rivier J, Judd HL, Chang RJ. Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women. J Clin Endocrinol Metab 1984; 58: 755–757.
   PubMed Web of Science ®Google Scholar
• Rajfer J, Swerdloff RS, Heberr DM. Testicular histology following chronic gonadotropin-releasing hormone agonist treatment. Fertil Steril 1984; 42: 765–771.
   PubMed Web of Science ®Google Scholar
• SmithJr JA, Urry RL. Testicular histology after prolonged treatment with a GnRH analogue. J Urology 1985; 133: 612–614.
   PubMed Web of Science ®Google Scholar
• Sharpe RM. Cellular aspects of the inhibitory action of LH-RH on the ovary and testis. J Reprod Fertil 1982; 64: 517–527.
   PubMedGoogle Scholar
• Spratt DI, Chin WW, Ridgway CE, CrowleyJr WF. Administration of low dose pulsatile gonadotropin-releasing hormone (GnRH) to GnRH-deficient men regulates free α-subunit secretion. J Clin Endocrinol Metab 1986; 62: 102–108.
   PubMed Web of Science ®Google Scholar
• Varenhorst E, Carlström K, Karlberg BE, Risberg B, Wallentin L, Wranne B. Risikofaktoren für kardiovaskuläre Komplikationen während der Behandlung des Prostatakarzinoms mit Östrogenen. Urologe 1982; 21: 34–38.
   Google Scholar